News

New published data generated with Genoskin human skin assays Genoskin assays are designed for fast and reliable studies with reproducible results. As we aim to empower research teams with the best technology to generate better human data, we are proud to discover new published data involving our skin assays.  The potential to evaluate nanoparticles toxicity In NanoImpact, a research teamRead more

Genoskin reinforces R&D capabilities Genoskin Research & Development offers new services to portfolio available to partners with the addition of new equipment. Genoskin's R&D recently added a Meso Scale QuickPlex SQ120 for high-performance electroluminescence immunoassays. This new instrument will enable our teams to detect the presence of biomarkers down to femtoscale concentrations. Genoskin also added a best-in-class solar simulator (Solar Light) capable ofRead more

Genoskin's CEO, Pascal Descargues to speak at the first FACCNE 'Café des Sciences' of 2020! Meet our CEO Pascal at the WeWork building on January 23  and discover everything about our real live human skin assays.  2020 welcomes a new year of Café des Sciences, and Pascal is the first speaker invited! Pascal will give a presentation on how toRead more

Incospharm publishes results using NativeSkin® Korean company Incospharm publishes data generated using our hi-tech human skin assay, NativeSkin®, in the International Journal of Molecular Sciences. Incospharm developed an innovative complex of peptides meant to stimulate the skin basement membrane proteins expression for anti-aging effects. The ex vivo evaluation using NativeSkin® confirmed that the topical application of this peptide complex significantlyRead more

Genoskin invited at FDA to present ex vivo human skin models validation data On November 14th, 2019, Pascal Descargues (Chief Executive Officer) and Eric Merle (Chief Commercial Officer) were invited by the FDA Immunotoxicology Interest group of the US Food and Drug Administration in Silver Spring, MD to present at the FDA Toxicology Seminar Series on HypoSkin® and NativeSkin® validation data. GenoskinRead more

Dr. Michael Pastore to speak at the Skin Models in Cosmetic Science Conference Today starts the conference on Skin Models in Cosmetic Science: Bridging Established Methods and Novel Technologies, organized by Le Studium in Tours, France. Genoskin’s Business Development Manager, Michael Pastore, Pharm.D., Ph.D. has been invited to speak during the second session on Human Reconstructed Skin in Cosmetic Sciences.Read more